349 related articles for article (PubMed ID: 28240787)
61. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
Liebman HA
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
[TBL] [Abstract][Full Text] [Related]
62. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children.
Glanz J; France E; Xu S; Hayes T; Hambidge S
Pediatrics; 2008 Mar; 121(3):e506-12. PubMed ID: 18310170
[TBL] [Abstract][Full Text] [Related]
63. Chronic refractory immune thrombocytopenia in adolescents and young adults.
Schifferli A; Le Gavrian G; Aladjidi N; Moulis G; Godeau B; Kühne T
Br J Haematol; 2023 Oct; 203(1):36-42. PubMed ID: 37735549
[TBL] [Abstract][Full Text] [Related]
64. Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group.
Kühne T; Berchtold W; Michaels LA; Wu R; Donato H; Espina B; Tamary H; Rodeghiero F; Chitlur M; Rischewski J; Imbach P;
Haematologica; 2011 Dec; 96(12):1831-7. PubMed ID: 21880634
[TBL] [Abstract][Full Text] [Related]
65. [Influencing Factors in the Chronicity of Immune Thrombocytopenia in Children].
Wang LY; Liu KK; Chu JH; Yang LH; Xie ZW; Zhang KL; Chai HJ; Wu ZY; Wang NL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):881-886. PubMed ID: 34105488
[TBL] [Abstract][Full Text] [Related]
66. Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan.
Hato T; Shimada N; Kurata Y; Kuwana M; Fujimura K; Kashiwagi H; Takafuta T; Murata M; Tomiyama Y
Blood Adv; 2020 Apr; 4(8):1648-1655. PubMed ID: 32320469
[TBL] [Abstract][Full Text] [Related]
67. Drug-induced immune thrombocytopenia: a descriptive survey in the French PharmacoVigilance database.
Moulis G; Sommet A; Sailler L; Lapeyre-Mestre M; Montastruc JL;
Platelets; 2012; 23(6):490-4. PubMed ID: 22098130
[TBL] [Abstract][Full Text] [Related]
68. Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms.
Schmidt DE; Heitink-Pollé KMJ; Laarhoven AG; Bruin MCA; Veldhuisen B; Nagelkerke SQ; Kuijpers TW; Porcelijn L; van der Schoot CE; Vidarsson G; de Haas M
Blood Adv; 2019 Jul; 3(13):2003-2012. PubMed ID: 31270082
[TBL] [Abstract][Full Text] [Related]
69. Idiopathic thrombocytopenic purpura complicating pregnancy.
Kelton JG
Blood Rev; 2002 Mar; 16(1):43-6. PubMed ID: 11913994
[TBL] [Abstract][Full Text] [Related]
70. Platelet transfusion practices in immune thrombocytopenia related hospitalizations.
Goel R; Chopra S; Tobian AAR; Ness PM; Frank SM; Cushing M; Vasovic L; Kaicker S; Takemoto C; Josephson CD; Nellis M; Bussel J; Krishnamurti L
Transfusion; 2019 Jan; 59(1):169-176. PubMed ID: 30520045
[TBL] [Abstract][Full Text] [Related]
71. Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort.
Rosthøj S; Rajantie J; Treutiger I; Zeller B; Tedgård U; Henter JI;
Acta Paediatr; 2012 Jul; 101(7):761-6. PubMed ID: 22429281
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia.
Adly AA; Ragab IA; Ismail EA; Farahat MM
Platelets; 2015; 26(7):645-50. PubMed ID: 25350586
[TBL] [Abstract][Full Text] [Related]
73. Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia.
Zhou F; Xu Y; Zhang Z; Wu X; Jin R
J Pediatr Hematol Oncol; 2015 Apr; 37(3):e158-61. PubMed ID: 25493457
[TBL] [Abstract][Full Text] [Related]
74. Presentation and outcome of idiopathic thrombocytopenic purpura in a single Australian centre.
Choi PY; Gordon JE; Harvey M; Chong BH
Intern Med J; 2012 Jul; 42(7):841-5. PubMed ID: 22805691
[TBL] [Abstract][Full Text] [Related]
75. Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients.
Dolasik I; Birtas Atesoglu E; Tarkun P; Mehtap O; Keski H; Dogru A; Hacihanefioglu A
Platelets; 2015; 26(3):220-3. PubMed ID: 24749912
[TBL] [Abstract][Full Text] [Related]
76. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura.
Neunert CE; Buchanan GR; Imbach P; Bolton-Maggs PH; Bennett CM; Neufeld EJ; Vesely SK; Adix L; Blanchette VS; Kühne T;
Blood; 2008 Nov; 112(10):4003-8. PubMed ID: 18698007
[TBL] [Abstract][Full Text] [Related]
77. Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis.
Heitink-Pollé KM; Nijsten J; Boonacker CW; de Haas M; Bruin MC
Blood; 2014 Nov; 124(22):3295-307. PubMed ID: 25305206
[TBL] [Abstract][Full Text] [Related]
78. [Clinical Analysis of Hospitalized Children with Primary Immune Thrombocytopenia].
Li RW; Fu RF; Chen YF; Liu W; Xue F; Li HY; Zhang L; Yang RC; Liu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):574-580. PubMed ID: 33812433
[TBL] [Abstract][Full Text] [Related]
79. Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration.
Zeller B; Helgestad J; Hellebostad M; Kolmannskog S; Nystad T; Stensvold K; Wesenberg F
Pediatr Hematol Oncol; 2000; 17(7):551-8. PubMed ID: 11033730
[TBL] [Abstract][Full Text] [Related]
80. Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis.
Weycker D; Hanau A; Hatfield M; Wu H; Sharma A; Bensink ME; Chandler D; Grossman A; Tarantino M
J Med Econ; 2020 Feb; 23(2):184-192. PubMed ID: 31547724
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
